Solianne M. Martínez-Jimenez

Dr. Solianne M. Martínez-Jimenez

Neuroscience, Universidad Central del Caribe, Bayamón, Puerto Rico, Puerto Rico
orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2019 in Biomolecules
Verified
Journal Article
Open access
PDF file
AMAntonio Henrique Martins
Antonio Henrique Martins
AZAstrid Zayas-Santiago
Astrid Zayas-Santiago
YFYancy Ferrer-Acosta
Yancy Ferrer-Acosta
Solianne M. Martínez-JimenezSolianne M. Martínez-Jimenez
Solianne M. Martínez-Jimenez
LZLidia Zueva
Lidia Zueva
Mikhail InyushinMikhail Inyushin
Mikhail Inyushin
It is well known that amyloid beta (Aβ) peptides are generated in blood vessels, released into the brain during thrombosis, and temporarily accumulate in this organ after injury. Here we demonstrate that 24 h after transient middle cerebral artery occlusion (tMCAO), one of the standard models of focal ischemic stroke, Aβ peptide accumulates in the brain, concentrating on the blood vessel walls. Because Aβ oligomers are known to induce significant damage to brain cells, they act as an additional damaging factor during ischemic stroke. Considering that they have been shown to form ion channels in cells, affecting osmotic balance, we used an Aβ peptide channel blocker, tromethamine (2-amino-2-(hydroxymethyl) propane-1,3-diol), to prevent this additional injury. Tromethamine injected 0.1 g/100 g body weight intraperitoneally at 5 min before tMCAO decreased water content in the damaged hemisphere, as measured by dry brain weight. Congo red staining, which binds only to Aβ oligomer plaques (amyloid), showed that there was no significant presence of plaques. Therefore, we suggest that Aβ peptide oligomers are responsible for some of the brain damage during stroke and that blockage of the ion channels that they form could be beneficial in treating this complex neurological syndrome.

21 October 2017 in Journal of Visualized Experiments
Verified
Journal Article
Open access
PDF file
YFYancy Ferrer-Acosta
Yancy Ferrer-Acosta
MGMaxine N. Gonzalez-Vega
Maxine N. Gonzalez-Vega
DRDavid E. Rivera-Aponte
David E. Rivera-Aponte
Solianne M. Martínez-JimenezSolianne M. Martínez-Jimenez
Solianne M. Martínez-Jimenez
MAMartins AH
Martins AH
Ischemic stroke is a complex brain injury caused by a thrombus or embolus obstructing blood flow to parts of the brain. This leads to deprivation of oxygen and glucose, which causes energy failure and neuronal death. After an ischemic stroke insult, astrocytes become reactive and proliferate around the injury site as it develops. Under this scenario, it is difficult to study the specific contribution of astrocytes to the brain region exposed to ischemia. Therefore, this article introduces a methodology to study primary astrocyte reactivity and proliferation under an in vitro model of an ischemia-like environment, called oxygen glucose deprivation (OGD). Astrocytes were isolated from 1-4 day-old neonatal rats and the number of non-specific astrocytic cells was assessed using astrocyte selective marker Glial Fibrillary Acidic Protein (GFAP) and nuclear staining. The period in which astrocytes are subjected to the OGD condition can be customized, as well as the percentage of oxygen they are exposed to. This flexibility allows scientists to characterize the duration of the ischemic-like condition in different groups of cells in vitro. This article discusses the timeframes of OGD that induce astrocyte reactivity, hypertrophic morphology, and proliferation as measured by immunofluorescence using Proliferating Cell Nuclear Antigen (PCNA). Besides proliferation, astrocytes undergo energy and oxidative stress, and respond to OGD by releasing soluble factors into the cell medium. This medium can be collected and used to analyze the effects of molecules released by astrocytes in primary neuronal cultures without cell-to-cell interaction. In summary, this primary cell culture model can be efficiently used to understand the role of isolated astrocytes upon injury.

6 March 2023 in Pharmacology
Verified
Journal Article
Closed access
PDF file
MCMaria Crespo
Maria Crespo
MRMarie Román
Marie Román
GTGuillermo Tirado
Guillermo Tirado
AMAntonio Henrique Martins
Antonio Henrique Martins
YFYancy Ferrer-Acosta
Yancy Ferrer-Acosta
Solianne M. Martínez-JimenezSolianne M. Martínez-Jimenez
Solianne M. Martínez-Jimenez
Introduction: A cerebral vasospasm (CVSP) is a potent vasoconstriction of the cerebral vasculature and the primary cause of morbidity and mortality following a subarachnoid hemorrhage. The middle cerebral artery (MCA) is commonly affected by CVSPs. Concomitant administration of dantrolene and nimodipine synergistically reduces vasospasms in aortic rings from Sprague Dawley rats. To determine if the effects observed in the systemic vasculature extend to the cerebral circulation, we investigated the effect of intravenous administration of dantrolene (2.5 mg/kg) and nimodipine (1 mg/kg and 2 mg/kg) on MCA blood flow velocity (BFV) 7 days after the induction of CVSPs. Methods: Vasospasms were induced by bathing the left common carotid artery with autologous whole blood. Age-matched sham rats were used as controls. BFV, mean arterial pressure (MAP), and heart rate (HR) were measured with a PeriFlux 5000 Laser Doppler System, and a CODA non-invasive blood pressure system, before and after administering the drugs. Morphometric evaluations were also performed to assess vascular alterations. Results: BFV was reduced by 37% with dantrolene alone (n = 6, p ≤ 0.05) and by 27% with 2 mg/kg nimodipine (n = 6, p < 0.05), while it was not affected by 1 mg/kg nimodipine. The combination of 1 mg/kg nimodipine with dantrolene, however, decreased BFV by 35% (from 435.70 ± 21.53 to 284.30 ± 23.13 perfusion units, n = 7, p ≤ 0.05). A similar reduction (31%) was obtained with dantrolene and 2 mg/kg nimodipine (from 536.00 ± 32.61 to 367.80 ± 40.93 perfusion units, n = 6, p ≤ 0.05). Neither MAP nor HR was affected by dantrolene or nimodipine alone. The combination of dantrolene with 2 mg/kg nimodipine, however, decreased MAP and increased HR. Furthermore, 7 days after the induction of vasospasms, lumen area of the left common carotid artery decreased, whereas media thickness and the wall-to-lumen ratio increased when compared to contralateral controls. The latter finding suggests that vascular remodeling was present at this stage. Conclusion: Altogether, our results indicate that 2.5 mg/kg dantrolene significantly reduces BFV in the MCA without altering systemic hemodynamic parameters to a similar extent than the highest dose of nimodipine or the combination of dantrolene and the lowest dose of nimodipine. Therefore, dantrolene may provide a promising alternative to lower the risk, or partially revert, CVSP.

Verified
Journal Article
Open access
PDF file
AÁAshlin Nicole Álvarez-Flores
Ashlin Nicole Álvarez-Flores
Fabiola Colon-SantiagoFabiola Colon-Santiago
Fabiola Colon-Santiago
NHNaiara I Hernández
Naiara I Hernández
Julieness CorreaJulieness Correa
Julieness Correa
SCSamuel Emir Caldero
Samuel Emir Caldero
Eduardo Alvarez-RiveraEduardo Alvarez-Rivera
Eduardo Alvarez-Rivera
Despite the remarkable success of antiretroviral therapy (ART) in suppressing human immunodeficiency virus type 1 (HIV-1) replication, viral persistence remains a major barrier to cure. This persistence is sustained by heterogeneous cellular reservoirs in which viral expression is tightly regulated by host-dependent molecular mechanisms. Beyond the canonical cluster of differentiation 4 (CD4+) T-cell reservoirs, HIV-1 establishes long-lived infection in myeloid cells, glial populations within the central nervous system (CNS), and additional non-canonical cellular niches, each characterized by distinct transcriptional, epigenetic, and immune environments. In this review, we synthesize recent advances in understanding how HIV-1 expression, latency, and reactivation are shaped across diverse susceptible cell types. We highlight cell-type-specific mechanisms governing viral integration, chromatin organization, transcriptional elongation, innate immune sensing, host restriction factors, and cytoskeletal regulation. Particular emphasis is placed on how host signaling pathways and immune microenvironments contribute to reservoir stability and heterogeneity, complicating eradication strategies. We further discuss immunomodulatory approaches that seek to modulate viral expression without exacerbating immune activation. By integrating molecular, cellular, and immunological perspectives, this review provides a framework for understanding HIV-1 persistence as a context-dependent process and underscores the need for cell-type-tailored strategies in HIV cure research.

Verified
Journal Article
Open access
PDF file
Eduardo Alvarez-RiveraEduardo Alvarez-Rivera
Eduardo Alvarez-Rivera
PRPamela Rodriguez-Vega
Pamela Rodriguez-Vega
Fabiola Colon-SantiagoFabiola Colon-Santiago
Fabiola Colon-Santiago
ARArmeliz Romero-Ponce
Armeliz Romero-Ponce
FUFabiola Umpierre-Lebron
Fabiola Umpierre-Lebron
Solianne M. Martínez-JimenezSolianne M. Martínez-Jimenez
Solianne M. Martínez-Jimenez
Stroke has been a topic of extensive research due to its debilitating consequences and high mortality. New findings offer a deeper understanding of specific factors that affect post-stroke recovery and identify therapies that may facilitate this process. One such factor is post-stroke neuroinflammation, a complex and time-dependent process in which acute immune responses can cause significant secondary inflammatory damage if the process is prolonged. Microglia are neuronal immune cells that are highly reactive to cytokines in the neuroenvironment and can, in turn, affect the inflammatory cascades that originate after stroke, making them ideal candidates for immunomodulation in the brain. Many FDA-approved immunotherapies have been found to target distinct inflammatory signaling molecules and responders, including IL-6 inhibitors, IL-13 inhibitors, IL-12/IL-23 inhibitors, B-cell modulators, type I interferon inhibitors, CAR T-cell therapy, calcineurin inhibitors, complement inhibitors, and JAK-STAT pathway inhibitors. The FDA-approved immunotherapies discussed in this review demonstrate potential in modulating the immune response after stroke by targeting key inflammatory pathways involved in secondary brain injury. Future research should focus on defining optimal therapeutic windows, identifying suitable patient populations, determining the most appropriate timing of therapy, and targeting specific immune mechanisms to balance the attenuation of harmful inflammation with the preservation of reparative processes.

21 August 2025 in International Journal of Research in Dermatology
Verified
Journal Article
Closed access
PDF file
IEItzamar Pastrana Echevarria
Itzamar Pastrana Echevarria
ACAlicia Baez Cruz
Alicia Baez Cruz
Solianne M. Martínez-JimenezSolianne M. Martínez-Jimenez
Solianne M. Martínez-Jimenez
ELEneida De La Torre Lugo
Eneida De La Torre Lugo
Background: Skin cancer incidence is rising in Puerto Rico. However, there is limited data on sunscreen knowledge and behaviors. This study evaluates these factors in Puerto Rico’s metropolitan area to identify barriers to effective sun protection and address a critical gap in the literature. Methods: A 31-question survey evaluated sunscreen behaviours, knowledge and perceptions among 205 adults in Puerto Rico's metropolitan area. Participants were recruited via QR codes and clinic referrals, with data analyzed using descriptive statistics, Chi-square and t-tests with significance set at p<0.05. Results: While 83.41% acknowledged sunscreen’s role in preventing skin cancer, only 33.17% reported daily application. Among those who use sunscreen, 21.0% reported that they do not reapply it throughout the day. Additionally, 13.17% stated that timing of application does not matter as long as sunscreen is applied. Half of participants (50.24%) reported using an arbitrary amount instead of the recommended 1 ounce (approximately a shot-glass full) for full-body coverage. Females reported significantly higher daily use (39.74% vs. 14.81%, p=0.001) and greater concern about skin cancer all the time (40.40% vs 14.81%, p<0.0001). Younger adults had higher sunburn rates (84.62% vs. 50.88%, p<0.001) and more frequently identified the correct reapplication interval (48.35% vs. 23.68%, p<0.001). Conclusions: The study highlights critical gaps in sunscreen use and knowledge specific to Puerto Rico, particularly among younger adults and males. Targeted education on correct sunscreen uses and the risks of inadequate protection is essential to reduce the rising incidence of skin cancer in Puerto Rico.